MDaaS Global
Techstars '18Boston, US · Founded 2017 · Delaware corporation · 68 employees on LinkedIn · 10 known investors
Find your way into MDaaS Global
Sign up to see every warm intro you have to MDaaS Global
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MDaaS Global team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MDaaS builds digital health infrastructure and services for healthcare providers across Africa. The company serves clinicians and patients by improving healthcare accessibility and quality in the region.
Also known as BeaconHealth Diagnostics · MDaaS · Medical Devices as a Service
Founders & leadership
MDaaS Global was founded in 2017 by Oluwasoga Oni, Genevieve Barnard Oni, and Joe McCord.



Board

Investors · 10
How we know: Aruwa Capital's portfolio page · nairametrics.com · Not right? Tell us
How we know: Consonance Investment Managers's portfolio page · Not right? Tell us
How we know: FINCA Ventures's portfolio page · Not right? Tell us
How we know: Flying Doctors Healthcare Investment Company's portfolio page · Not right? Tell us
How we know: Future Africa's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Newtown Partners's portfolio page · research · techcrunch.com · Not right? Tell us
How we know: the Techstars portfolio · funding news · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ventures Platform's portfolio page · ventureburn.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$1.1M disclosed across 1 of 4 rounds · 2019–2026
- Undisclosed amountpre-Series AMar 2024 · 2 sources
Aruwa Capital (lead), Aruwa Capital Management (lead), Newton Partners (lead), Newtown Partners (lead), Ventures Platform
Source ↗ - Undisclosed amountseed extensionJun 2021 · 2 sources
Newtown Partners (lead)
Source ↗
▶$1.1MraisedApr 2019 · 12 investors · Other TechnologyRule 506(b)
- Oluwasoga OniExecutive Officer, Director
- Mobolaji AdeoyeDirector
- Genevieve OniExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Sep 2026MDaaS Global is a healthtech company that builds and operates tech-enabled diagnostic clinics under the BeaconHealth Diagnostics brand, primarily in Nigeria and, since 2024, in Cameroon. Its centers provide imaging (digital x-ray, ultrasound), cardiac services (ECG, echocardiography) and laboratory services spanning chemistry analysis, immunoassay and hematology, with chest x-ray, urinalysis and full blood count among the most frequently performed procedures. The company describes four lines of work: clinics, technology, logistics (secure handling and transport of samples and consumables) and public health (distribution and data).
The technology layer is BeaconOS, a proprietary platform described as an operating system for the company's own and affiliate diagnostic facilities, giving visibility into day-to-day center operations and handling patient visits and clinical results. Applications built on BeaconOS include Olewerk for diagnostic workflow optimization and Beam, a partner-facing product for corporate occupational health management. SentinelX is a preventive-care product, originally consumer-facing, that the company repositioned toward corporate customers for annual employee screenings, pre-employment screenings and government-mandated screenings. MDaaS also markets its clinical data repository for clinical trials, test development, population health, precision medicine and AI-assisted diagnosis, and launched Lucent and Hazel AI in 2025.
Alongside company-owned centers, MDaaS runs a referral and affiliate network of clinicians, hospitals, pharmacies, healthtech startups, corporate partners and HMOs, and has stated plans to extend coverage to all 36 Nigerian states through a mix of owned and affiliate clinics.
Founding story
The concept originated from CEO Oluwasoga Oni's childhood exposure to his father's rural Nigerian hospital and the difficulty such hospitals faced acquiring and maintaining medical equipment such as x-ray machines and ultrasound scanners. While studying in MIT's System Design and Management program in 2015, a class assignment to design a business capable of impacting a billion lives became the blueprint for the company. Oni co-founded MDaaS in January 2016 with MIT classmate Joe McCord, his partner Genevieve Barnard Oni, and operations lead Opeyemi Ologun. The name originally stood for "Medical Devices as a Service", reflecting an initial model of selling and leasing refurbished medical equipment to small hospitals; when clinics proved unable to fund purchases, the company pivoted to building its own diagnostic centers in underserved communities.
Business model
MDaaS owns and operates diagnostic centers and extends reach through affiliate clinics that connect into its BeaconOS platform, supported by in-house logistics for samples and consumables. Revenue comes from diagnostic imaging, cardiac and laboratory services delivered to individual patients, from corporate clients purchasing annual, pre-employment and government-mandated employee screenings via SentinelX and Beam, and from referrals routed through partner clinicians, hospitals, pharmacies and HMOs. The company has said it tapped new dollar revenue sources in 2023 in response to naira devaluation.
Fee-for-service diagnostics at owned and affiliate clinics, corporate screening contracts (including one-time annual access fees under SentinelX), and HMO-reimbursed testing.
Traction
The website reports 650,000+ patients served, 1,300+ clinical partners, an NPS of 93 and presence in 25+ cities. In 2023 the company served 108,724 patients (60.8% women) and performed over 240,000 diagnostic tests, maintaining an NPS above 90 and a 4.7-star average Google rating across 18 locations; cumulative patients served passed 250,000 at end-2023 and 275,000 by March 2024, with the company reporting 500,000 patients and over one million tests in 2025. It works with over 1,300 referring clinicians across more than 1,000 organizations and 34 HMOs. Headcount reached 200 after onboarding 66 people in 2023.
Latest developments
In March 2024 MDaaS announced a $3 million pre-Series A round co-led by Aruwa Capital Management and Newtown Partners with follow-on from Ventures Platform, bringing total investment to $6.8 million, to build out BeaconOS and extend the clinic network to all 36 Nigerian states. In 2024 it opened five new centers, including its first outside Nigeria in Douala, Cameroon, and launched Beam. In 2025 it opened seven further sites, launched Lucent and Hazel AI, raised a pre-Series A round, and reported reaching 500,000 patients served and more than one million tests performed. Newsroom items also reference Mulago Foundation support for scaling diagnostics in Nigeria and an inaugural MIT Africa Business Club Alumni Impact Award for the CEO.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
MDaaS describes BeaconHealth as Nigeria's fastest-growing healthcare network and itself as the preferred diagnostics provider for more than 100 companies, citing what it calls Africa's largest clinical data repository. It positions against a backdrop in which the WHO Regional Committee for Africa estimated in 2023 that only about 30% of African health facilities have equipment for basic diagnostic tests.
The company pairs physical diagnostic infrastructure in underserved locations with an in-house software stack (BeaconOS and its applications) and its own sample logistics, rather than operating clinics or software alone, and uses the resulting clinical data for research, population health and AI-assisted diagnosis initiatives.
Technology
BeaconOS is the company's proprietary operating system for diagnostic facilities, deployed across all centers by mid-2023 after a Lagos pilot, providing operational visibility and management of patient visits and clinical results for both owned and affiliate locations. Applications on top of it include Olewerk (diagnostic workflow optimization) and Beam (corporate occupational health). Planned modules include an affiliate clinic portal for real-time referrals, results management and quality control, digital HMO integrations for authorizations and claims, and a patient app for bookings, results, follow-up care and insurance enrollment. Other products include SentinelX, an in-house molecular laboratory, and Lucent and Hazel AI, launched in 2025.
Go-to-market
Growth combines opening company-owned full-service centers, smaller embedded sites and "spikes" in new cities with an affiliate clinic model and a referral network of clinicians and organizations. Corporate and HMO relationships supply recurring screening volume, and partnerships with organizations such as CancerAware Nigeria, the Access Bank W Initiative and Livelihood Impact Fund provide subsidized services that also build community trust.
Patients in clinically underserved Nigerian and African communities, with women making up roughly 60% of patients; referring clinicians, hospitals, pharmacies and healthtech startups; corporate employers requiring occupational health and employee screening; and health maintenance organizations.
Geography
Headquartered in Lagos, Nigeria (70 Fatai Arobieke Street, Lekki Phase 1), with a network reported at 17 diagnostic centers across 10 Nigerian states in March 2024 and 18 center locations reported for 2023; the website cites presence in 25+ cities. Center locations named include Ibadan, Ilorin, Osogbo, Lekki, Offa, Sangotedo, Abuja, Gbagada, Akure, Uyo, Ikeja, Sango-Ota, Victoria Island, Port Harcourt, Ado-Ekiti, Benin, Lokoja, Owerri, Bodija, Akobo, Kano and Share. The company expanded outside Nigeria for the first time in 2024 with a clinic in Douala, Cameroon.
History
MDaaS launched in 2016 as an equipment supply business and opened its first diagnostics center, Sunrise Diagnostics, in Ibadan in November 2017. In 2018 it joined the Techstars accelerator and secured institutional investment from Techstars and Ventures Platform. The clinic brand was renamed from Sunrise to BeaconHealth in 2019, when a second center opened in Ilorin. In 2020 it added two centers (Osogbo and an embedded site), launched SentinelX, partnered with Flying Doctors Nigeria on a sample collection center in Sango-Ota, and was runner-up for Africa's Business Heroes. Five centers followed in 2021 alongside a seed round extension and a move to a new headquarters office, and six more in 2022 with the launch of Medverse Logistics and an in-house molecular laboratory. In 2023 the company opened BeaconHealth Abuja, piloted and then deployed BeaconOS across all centers, and raised growth investment. Five centers opened in 2024, including the company's first outside Nigeria in Douala, Cameroon, and Beam launched. In 2025 seven further sites opened (four full service and three "spikes"), Lucent and Hazel AI launched, the company raised a pre-Series A round, and it reported reaching 500,000 patients served and more than one million tests performed.
Risks & controversies
The company has cited a slow fundraising process that forced it to pause center expansion, high inflation raising the cost of medical consumables, and significant naira devaluation under changing Nigerian economic policy. It responded by centralizing purchasing, cutting net burn by more than half, and seeking dollar-denominated revenue. Its consumer-facing SentinelX product underperformed as a B2C offering and was repositioned for business customers.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 14
launches, deals, and filingsFour full-service centers (Owerri, Bodija 1, Akobo, Kano) and three 'spikes' (Bodija 2, Lekki 2, Share).
Round co-led by Aruwa Capital Management and Newtown Partners with follow-on from Ventures Platform, bringing total investment to date to $6.8 million; proceeds earmarked for BeaconOS development and network expansion to all 36 Nigerian states.
$3M source ↗
Opened five new full-service centers in 2024, four in Nigeria (Port Harcourt, Ado-Ekiti, Benin, Lokoja) and one in Douala, Cameroon, the company's first country outside Nigeria.
Partner-facing application enabling corporate partners to manage occupational health for their teams.
Provides affordable eyewear to patients across the BeaconHealth Diagnostics network; MDaaS also continued cancer-screening partnerships with CancerAware Nigeria and the Access Bank W Initiative.
After a Lagos pilot, the BeaconOS facility operating system was deployed across all MDaaS diagnostic centers by the end of Q2 2023.
First application built on BeaconOS, for optimizing diagnostic workflows, deployed across all 17 locations.
Launched as 'Sunrise Diagnostics'; renamed BeaconHealth in 2019.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 8
primary sources listed
- MDaaS Globalmdaas.io · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does MDaaS Global do?
- MDaaS Global operates the BeaconHealth network of tech-enabled diagnostic clinics in clinically underserved African communities.
- Who founded MDaaS Global?
- MDaaS Global was founded by Oluwasoga Oni, Genevieve Barnard Oni, Joe McCord in 2017.
- Who are MDaaS Global's investors?
- MDaaS Global's investors include Aruwa Capital, Consonance Investment Managers, FINCA Ventures, Flying Doctors Healthcare Investment Company, Future Africa, Newtown Partners, Techstars, Ventures Platform.
- How much funding has MDaaS Global raised?
- MDaaS Global has disclosed $1.1M raised across 1 of its 4 known rounds.
- Where is MDaaS Global headquartered?
- MDaaS Global is headquartered in Boston, US.



